Table 1.
Baseline characteristics of the participants.
| HCC (%) | At-risk (%) | HC (%) | Statistics χ2 | P value | |
|---|---|---|---|---|---|
| N | 104 | 95 | 174 | ||
| Gender | |||||
| Male | 83 (79.8) | 56 (58.9) | 100 (57.5) | 15.562 | <0.001 |
| Female | 21 (20.2) | 39 (41.1) | 74 (42.5) | ||
| Age | |||||
| 0-50 | 33 (31.7) | 36 (37.9) | 83 (47.7) | 7.307 | 0.026 |
| >50 | 71 (68.3) | 59 (62.1) | 91 (52.3) | ||
| Cirrhosis | |||||
| Yes | 80 (76.9) | 63 (66.3) | NA | 2.762 | 0.097 |
| No | 24 (23.1) | 32 (33.7) | NA | ||
| Etiology | |||||
| HBV | 89 (85.6) | 59 (62.1) | NA | 23.353 | <0.001 |
| HCV | 10 (9.6) | 7 (7.4) | NA | ||
| Alcoholic | 2 (1.9) | 8 (8.4) | NA | ||
| Others | 3 (2.9) | 21 (22.1) | NA | ||
| AFP | |||||
| 0-20 ng/mL | 44 (42.3) | 82 (86.3) | 171 (98.3) | 129.220 | <0.001 |
| >20 ng/mL | 60 (57.7) | 13 (13.7) | 3 (1.7) | ||
| BCLC stage | |||||
| A | 46 (44.2) | ||||
| B | 27 (26.0) | ||||
| C/D | 23 (22.1) | ||||
| Unknown | 8 (7.7) |
HCC indicates hepatocellular carcinoma. HC indicates healthy control. At-risk indicates noncancerous liver diseases, including cirrhosis and hepatitis. HBV indicates hepatitis B virus, HCV indicates hepatitis C virus, AFP indicates alpha fetoprotein, and BCLC stage indicates Barcelona Clinic Liver Cancer.